Genomic Unit for the Diagnosis of Human Pathologies, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy.
Clin Chem Lab Med. 2012 Jan 9;50(6):1021-9. doi: 10.1515/cclm-2011-0854.
Age-related macular degeneration (AMD) is a multifactorial disease for which an involvement of alterations in the retinal ABC transporter gene (ABCA4) is still debated. Oxidative stress in retinal pigment epithelial cells has been postulated to contribute to the pathogenesis of the disease. Mitochondrial ferritin (FtMt), an iron-sequestering protein, is expressed in cell types characterized by high metabolic activity and oxygen consumption, including human retina, suggesting a role in protecting mitochondria from iron-dependent oxidative damage. Based on these findings we wanted to investigate whether mutations in this gene could be found in AMD patients.
Mutational scanning of the FTMTgene was performed in a cohort of 50 patients affected by age-related macular degeneration. The ABCA4 gene was also scanned in one patient carrying an FtMt mutation. In silico analyses were carried out on the identified variants. The recombinant form of FtMt variant was expressed in Escherichia coli and biochemically characterized.
One patient was found to be heterozygous for two previously unreported genetic changes: a complex FtMt mutation (c.437_450delinsCT: delAGGACATCAAGAAGinsCT) and a missense p.Leu973Phe (c.2919G>T) mutation in exon 20 of ABCA4. Computational analyses predicted a severe structural impairment for FtMt variant and a mild destabilizing effect for ABCA4. E. coli expression of recombinant FtMt variant yielded a highly insoluble protein that could not be renatured under in vitro conditions suitable for wild-type ferritins.
Our findings suggest that the FtMt mutation may determine a condition similar to haploinsufficiency resulting in a reduced protection from iron-dependent oxidative stress in mitochondria.
年龄相关性黄斑变性(AMD)是一种多因素疾病,其视网膜 ABC 转运蛋白基因(ABCA4)的改变仍存在争议。氧化应激在视网膜色素上皮细胞中被认为有助于疾病的发病机制。线粒体铁蛋白(FtMt)是一种铁结合蛋白,在代谢活性和耗氧量高的细胞类型中表达,包括人视网膜,这表明它在保护线粒体免受铁依赖性氧化损伤方面发挥作用。基于这些发现,我们想研究是否可以在 AMD 患者中发现该基因的突变。
在 50 名年龄相关性黄斑变性患者的队列中进行了 FTMT 基因突变扫描。还在携带 FtMt 突变的一名患者中扫描了 ABCA4 基因。对鉴定的变体进行了计算机分析。在大肠杆菌中表达了 FtMt 变体的重组形式,并对其进行了生化表征。
发现一名患者为两种先前未报道的遗传变化的杂合子:复杂的 FtMt 突变(c.437_450delinsCT:delAGGACATCAAGAAGinsCT)和 ABCA4 外显子 20 中的错义 p.Leu973Phe(c.2919G>T)突变。计算分析预测 FtMt 变体的结构严重受损,而 ABCA4 的稳定性降低。大肠杆菌表达重组 FtMt 变体产生了一种高度不溶性的蛋白质,在适合野生型铁蛋白的体外条件下无法复性。
我们的研究结果表明,FtMt 突变可能导致类似于半合子不足的情况,从而导致线粒体中铁依赖性氧化应激的保护减少。